SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-09
👔
Vera Therapeutics, Inc.
@VERA_InsiderForm 4 Filing: Fordyce Marshall Sells $2.0M of $VERA
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Vera Therapeutics, Inc.
Ticker: $VERA
Transaction Value
$2.0M
Price/Share: $42.30
transaction date
2026-07-07
Shares: 46,250
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Fordyce Marshall, holds the title of PRESIDENT AND CEO at Vera Therapeutics, Inc..
On 2026-07-07, the insider transacted 46,250 shares.The shares were transacted at a weighted average price of $42.30 per share, resulting in a total market-relevant value of $2.0M.
Executive Summary Summary
Fordyce Marshall (PRESIDENT AND CEO) sold $2.0M of $VERA
Post-Transaction Position: 164,694 shares
SEC Accession No: 0001859453-26-000010 (CIK: 1859453)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.